Pyrazolyl-ureas as kinase inhibitors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9884845
SERIAL NO

15118708

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

There are provided compounds of formula (I) as defined in the specification, which are p38 MAP kinase inhibitors for use as medicaments for the treatment inter alia of inflammatory diseases.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
RESPIVERT LIMITED50-100 HOLMERS FARM WAY HIGH WYCOMBE BUCKINGHAMSHIRE HP12 4EG

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Fordyce, Euan Alexander Fraser Nottingham, GB 23 274
King-Underwood, John Worcestershire, GB 45 988
Longshaw, Alistair Ian Nottingham, GB 21 301
Onions, Stuart Thomas Nottingham, GB 70 1138
Venable, Jennifer Diane Solana Beach, US 6 53
Walters, Iain Nottingham, GB 33 439

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Aug 6, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 6, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00